2006
DOI: 10.1016/j.cca.2006.08.031
|View full text |Cite|
|
Sign up to set email alerts
|

WITHDRAWN: Metabolic syndrome: Diagnosis, potential markers and management—an update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0
2

Year Published

2007
2007
2013
2013

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 0 publications
1
5
0
2
Order By: Relevance
“…These results extend previously shown effects of a healthy lifestyle for the risks of the metabolic syndrome and for cardiovascular disease to the domain of cognitive function [84,85] . Future therapeutic interventions that try to preserve and improve memory functions in the elderly may profit from similar comprehensive approaches.…”
Section: Discussionsupporting
confidence: 79%
“…These results extend previously shown effects of a healthy lifestyle for the risks of the metabolic syndrome and for cardiovascular disease to the domain of cognitive function [84,85] . Future therapeutic interventions that try to preserve and improve memory functions in the elderly may profit from similar comprehensive approaches.…”
Section: Discussionsupporting
confidence: 79%
“…Immunoglobulin elevation was selective, affecting only the IgA class, with the exception of an IgM increase in individuals with dyslipidaemia. The mechanisms of IgA elevation in individuals with obesity and metabolic syndrome are unknown, but IgA elevation is not surprising because both conditions are chronic inflammatory disorders [21,22]. Serum levels of IL‐6, an inflammatory marker, were associated with those of serum IgA.…”
Section: Discussionmentioning
confidence: 99%
“…An increase in serum IgA levels is a generalized phenomenon in diabetic patients [19,20]. Chronic inflammation is a key feature of type 2 diabetes, obesity and metabolic syndrome [21,22], a cluster of abnormalities characterized by insulin resistance along with specific risk factors including hyperglycaemia, visceral adiposity, dyslipidaemia and high blood pressure [23,24]. Production of proinflammatory cytokines is increased in patients with metabolic syndrome [25,26].…”
Section: Introductionmentioning
confidence: 99%
“…Omental adiposity [17,18] preceds the development of insulin resistance and T2D and is one of the major components of the metabolic syndrome. Since adipokines derived from omental adipose tissue are clearly involved in insulin resistance, dyslipidemia and coronary artery disease [1,19-21], new adipokines such as omentin might play an important role in the pathogenesis of T2D and associated metabolic disorders.…”
Section: Discussionmentioning
confidence: 99%